STI-5656

abivertinib maleate · Sorrento Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STI-5656, covering 2021-11-03 to 2021-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19 [Phase 2]

See pricing